Your browser doesn't support javascript.
loading
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
Despierre, Evelyn; Vergote, Ignace; Anderson, Ryan; Coens, Corneel; Katsaros, Dionyssios; Hirsch, Fred R; Boeckx, Bram; Varella-Garcia, Marileila; Ferrero, Annamaria; Ray-Coquard, Isabelle; Berns, Els M J J; Casado, Antonio; Lambrechts, Diether; Jimeno, Antonio.
Afiliação
  • Despierre E; Gynecologic Oncology and Leuven Cancer Institute, and Department of Oncology, KU Leuven, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. evelyndespierre@gmail.com.
  • Vergote I; Gynecologic Oncology and Leuven Cancer Institute, and Department of Oncology, KU Leuven, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Anderson R; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Coens C; EORTC Headquarters, Brussels, Belgium.
  • Katsaros D; Azienda Ospedaliera, Presidio Santa Anna, SCDO 3 Ginecologia Oncologica, Università di Torino, Turin, Italy.
  • Hirsch FR; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Boeckx B; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Varella-Garcia M; Vesalius Research Center (VRC), VIB, Leuven, Belgium.
  • Ferrero A; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Ray-Coquard I; Academic Division of Gynecological Oncology, Mauriziano Hospital, Turin, Italy.
  • Berns EM; Département d'Oncologie Médicale Adulte, Centre Leon Bérard, Lyon, France.
  • Casado A; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Lambrechts D; Hospital Universitario Clínico San Carlos, Servicio de Oncologia Medica, Madrid, Spain.
  • Jimeno A; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
Target Oncol ; 10(4): 583-96, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26004768
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Proteínas Quinases / Receptores ErbB / Cloridrato de Erlotinib Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Proteínas Quinases / Receptores ErbB / Cloridrato de Erlotinib Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Bélgica